Search our site

LCT to Present Positive Preliminary Clinical Result

23 September, 2008 - tse

Natural neo-natal porcine islets encapsulated in an alginate gel and transplanted for the treatment of insulin-dependent diabetes.

A choroid plexus cell product with the potential to treat neurological diseases such as Parkinson’s disease and stroke.

A liver cell product aimed at producing factor 8, a blood clotting agent absent or defective in people suffering haemophilia.

LCT’s technology platform involves the implantation of healthy living cells to replace, repair or regenerate diseased or damaged organs.

The Advances in Porcine Islet Implants for the Treatment of Type 1 Diabetes Symposium.